Doctors' views on hidden inflammation in heart and kidney patients surveyed
NCT ID NCT06589791
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This study surveyed 1,500 cardiologists and nephrologists in China to understand their awareness and perceptions of systemic inflammation in patients with both atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD). The goal was to see how doctors identify and manage inflammation in these patients. No treatments were tested; it was purely a knowledge-gathering survey.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE(CKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Shanghai Pharmaceuticals Co., Ltd
Shanghai, China
Conditions
Explore the condition pages connected to this study.